Tissue-specific transcription factor promoters have been exploited for generating tissue-specific expression of Cre, which leads to mutant p53 expression or knockdown of p53 only in the specific tissues [55], therefore, providing an opportunity to investigate the role of mutant p53 or p53 loss in sporadic tumor tissues during tumorigenesis and tumor development. The gene discussed is TP53; the disease is neoplasm.